Stock 4544 H.U. GROUP HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

H.U. Group Holdings, Inc.

Equities

4544

JP3822000000

Healthcare Facilities & Services

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-26 am EDT 		5-day change 1st Jan Change
2,416 JPY +0.86% Intraday chart for H.U. Group Holdings, Inc. +3.85% -9.29%
Apr. 26 H.U. Group Holdings, Inc. Announces Retirement of Atsuko Murakami as Executive Officer CI
Apr. 26 H.U. Group Holdings, Inc. Announces Retirement of Atsuko Murakami as Chief Financial Officer CI

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration

Latest news about H.U. Group Holdings, Inc.

H.U. Group Holdings, Inc. Announces Retirement of Atsuko Murakami as Executive Officer CI
H.U. Group Holdings, Inc. Announces Retirement of Atsuko Murakami as Chief Financial Officer CI
H.U Unit Fujirebio Diagnostics Partners Beckman Coulter in Neurodegenerative Diseases Field MT
Fujirebio and Beckman Coulter Expand Partnership to Develop Patient-Friendly, Blood-Based Neurodegenerative Disease Diagnostics CI
H.U. Group Holdings Inc. and Fujirebio Announces the Availability of the Lumipulse G pTau 217 Plasma Assay for the Fully Automated LUMIPULSE G Immunoassay Systems CI
Japanese Shares Rebound After Inflation Data, BoJ Rate Outlook MT
H.U. Group to Issue Stock Options to Directors, Employees MT
H.U. Group to Grant Share Options to Staff MT
H.U. Group Holdings, Inc. Revises Earnings Guidance for the Fiscal Year Ending March 31, 2024 CI
H.U. Group Holdings, Inc.(TSE:4544) dropped from FTSE All-World Index CI
H.U. Group Holdings' Fiscal Full-Year Profit Falls 47% MT
H.U. Group Holdings, Inc. Announces Dividend for the Year Ended March 31, 2023, Payable on May 30, 2023; Provides Dividend Guidance for the Second Quarter and Full Year Ending March 31, 2024 CI
H.U. Group Holdings, Inc. Provides Consolidated Earnings Forecasts for the Fiscal Year Ending March 31, 2024 CI
H.U. Group Holdings, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
H.U. Group Holdings, Inc. Announces Launch of the Fully Automated Lumipulse® G NfL CSF and Lumipulse® G NfL Blood tests CI
H.U. Group Holdings, Inc. Provides Consolidated Earnings Forecasts for the Fiscal Year Ending March 31, 2023 CI
H.U. Group Holdings, Inc. Provides Year End Dividend Forecast for the Fiscal Year Ending March 31, 2023 CI
H.U. Group Holdings, Inc. Provides Dividend Guidance for the Second Quarter-End and for the Full Year of Fiscal Year Ending March 31, 2023 CI
H.U. Group Holdings, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023 CI
Japan Equities End Week Higher; W-Scope Zooms 12% on Securing Approval for Unit's Listing in Korea MT
H.U. Group Unit to Acquire Biomarker Assays Developer for $42 million MT
H.U. Group Holdings, Inc. Provides Dividend Guidance for the Fiscal Year Ended March 31, 2022 CI
H.U. Group Unit Designates Managing Director MT
H.U. Group Holdings, Inc. Announces Board Changes CI
H.U. Group Holdings, Inc. Announces Launch of Fully Automated Lumipulse G ß-Amyloid 1-42 and ß-Amyloid 1-40 Plasma Assays for Research Use Only CI

Chart H.U. Group Holdings, Inc.

Chart H.U. Group Holdings, Inc.
More charts

Company Profile

H.U. Group Holdings Inc, formerly Miraca Holdings Inc is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and sterilization related business. The Company operates in four business segments. The Outsourced Clinical Testing segment accepts special tests from medical institutions. The Clinical Laboratory Medicine segment manufactures and sells clinical laboratory medicines and sells them to medical institutions and contract clinical laboratory companies. The Sterilization segment mainly entrusts the sterilization of medical equipment used for medical treatment in hospitals of large-scale hospitals and the related operations. The New Development & Others segment is involved in the homecare & welfare equipment business, self-medication & health insurance business, food & environment & cosmetics inspection business.
Sector
Healthcare Facilities & Services
Calendar
2024-05-09 - Q4 2023 Earnings Release
More about the company

Income Statement Evolution

More financial data

Ratings for H.U. Group Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
5
Last Close Price
2,416 JPY
Average target price
2,582 JPY
Spread / Average Target
+6.87%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
H.U. GROUP HOLDINGS, INC. Stock H.U. Group Holdings, Inc.
-9.29% 872M
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-17.89% 8.25B
RADNET, INC. Stock RadNet, Inc.
+39.20% 3.57B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-39.11% 2.46B
SYNLAB AG Stock SYNLAB AG
-8.06% 2.46B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
-7.35% 2.38B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-12.61% 1.81B
FLEURY S.A. Stock Fleury S.A.
-19.01% 1.55B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-40.66% 1.21B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+7.56% 1.11B
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. 4544 Stock
  4. News H.U. Group Holdings, Inc.
  5. H.U. Group to Issue Stock Options to Directors, Employees